Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,290 papers from all fields of science
Search
Sign In
Create Free Account
Adenine:MCnc:Pt:Ser:Qn
Known as:
adenina:concentración de masa:punto en el tiempo:suero:cuantitativo
, Adeniin:MCnc:Pt:S:Qn
, Adenine:Massa concentratie:Moment:Serum:Kwantitatief
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Adenine
Chemical procedure
Serum
Unit of Mass Concentration
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PENGARUH TEKNIK PENYEMAIAN DAN KONSENTRASI BENZIL-ADENIN (BA) PADA PERTUMBUHANBIBIT MANGGIS (Garcinia mangostana L.)ASAL BIJI
Hafis Baihaqi
2017
Corpus ID: 133712988
ABSTRAK Manggis (Garcinia mangostana L.) merupakan salah satu komoditas buah asli tropika yang mempunyai nilai ekonomis…
Expand
2016
2016
CB. Avaliação da atividade regulatória do riboswitch de guanina (purE) de Bacillus subtilis
Milca Rachel Da Costa Ribeiro Lins
,
G. G. Corrêa
,
D. B. Pedrolli
2016
Corpus ID: 90186999
Introducao: O metabolismo de purinas (guanina e adenina) em micro-organismos gera metabolitos com valor biotecnologico, podendo…
Expand
2014
2014
Aspectos clínicos e fisiopatológicos da Doença de Huntington
Anderson Martelli
2014
Corpus ID: 170397595
A doenca de Huntington (DH) e a mais comum das doencas neurodegenerativas autossomicas dominantes com inicio na idade adulta…
Expand
2008
2008
Reactivity of 5a,6-anhydrotetracycline platinum(II) complex with biological nucleophiles: a theoretical study
B. L. Marcial
,
Luiz Antônio
,
S. Costa
,
W. B. Almeida
,
H. Santos
,
Rua Santos
2008
Corpus ID: 55421928
-1 , respectively). These outcomes show that AHTC-Pt hybrid complex may be considered a promising lead compound in the…
Expand
2005
2005
Aspectos etiopatogênicos da Doença de Huntington
Juelto C. Fernandes Peixoto
,
Paulo Estevão Wandekoken Borlot
,
+4 authors
A. Gomes
2005
Corpus ID: 192542537
Review
2005
Review
2005
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the royal free hospital studies of hepatitis B virus carrier treatment: Identification of factors influencing response…
H. Thomas
,
L. Scully
,
A. Lever
,
I. Yap
,
M. Pignatelli
Infection
2005
Corpus ID: 28759537
SummaryWe have reviewed the results of treating over 100 HBV carriers with adenine arabinoside, adenine arabinoside monophosphate…
Expand
2005
2005
Comportamiento interfacial de la Adenina sobre electrodos metálicos.: Condensación sobre mercurio y adsorción sobre superficies monocristalinas de oro de bajos índices de Miller
César Prado Fernández
2005
Corpus ID: 171823055
Se han estudiado los aspectos cineticos de las transiciones de fase que experimentan la adenina al formar fases condensadas sobre…
Expand
2000
2000
Enteroviral and Immune Mediated Myocarditis in SCID mice
P. Schwimmbeck
,
G. Rohn
,
+6 authors
H. Schultheiss
Herz
2000
Corpus ID: 28957166
Severe combined immune deficiency (SCID) mice have been used as an animal model to study both the direct cytopathic effect of…
Expand
1984
1984
Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: Lack of correlation with DNA polymerase response
Y. Liaw
,
D. Lin
,
C. Chu
,
I. Sheen
,
T. J. Chen
Infection
1984
Corpus ID: 1604476
SummaryFifteen patients with HBsAg-positive, severe chronic active heptatitis, nine DNA polymerase (DNAP)-positive and six…
Expand
1980
1980
Vorläufige tierexperimentelle und klinische Erfahrungen mit dem Virustaticum Adenin-Arabinosid-Monophosphat bei Encephalitiden aus der Herpesgruppe und bei Varicella/Zoster-Infektionen
O. Sauer
,
E. Huth
,
+4 authors
Werner Gt
1980
Corpus ID: 164187594
Die bisher entwickelten Virustatica haben grostenteils die in sie gesetzten Erwartungen nicht erfullen konnen. Dies beruht…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE